NEW YORK, Nov. 6, 2019 /PRNewswire/ -- International producer of 100% certified organic herbal teas and supplements, Pukka Herbs has brought another powerful, delicious herbal product to

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- Ahlstrom-Munksjö announces the launch of TrustShield™, a versatile portfolio of medical fabrics that can be used to provide protection against surgical lasers, chemicals and potent chemotherapy drugs.TrustShield™ products were specially designed around growing market trends. The evolution of laser techn

STAMFORD, Conn., Nov. 6, 2019 /PRNewswire/ -- Stamford, Conn.-based private equity firm Olympus Partners (Olympus) has entered into a definitive agreement to acquire education and healthcare staffing provider Soliant Health (Soliant) from the Adecco Group. Soliant primarily provides therapists, including speech pathologists, psychologists

NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Hilco Streambank, a leading advisory firm specializing in the sale of intellectual property assets and related tangible property, has been retained  to market for sale a patent portfolio supporting the STB-FAST wound care technology platform, as well as related trademarks, trade secrets and specialized equipment used in th

SUNNYVALE, Calif., Nov. 6, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Suzanne Winter, the company's new Senior Vice President, Chief Commercial Officer.  As a material inducement to Ms. Winter joining the company, and in accordance

RICHMOND HILL, Ontario, Nov. 6, 2019 /PRNewswire/ -- CATHETRIX, an innovative developer of urinary (Foley) smart catheter fixations, has signed an agreement with Pro-Lab Diagnostics, a global distributer of medical products, for the di

NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Currently, there are over 1.5 million nonprofits registered in the U.S., including the nation's largest suicide prevention organization, the

PRINCETON, N.J., Nov. 6, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Daniel P. Ring, Vice President of Business Development and S

TARRYTOWN, N.Y. and ROCHESTER, Minn., Nov. 6, 2019 /PRNewswire/ -- Phase 2 trial will evaluate combination of PD-1 inhibitor Libtayo® (cemiplimab-rwlc) and oncolytic virus Voyager-V1; preclinical research collaboration will explore new oncolytic virus treatmentsVyriad to receive upfront payment and e

SÃO JOSÉ DO RIO PRETO, Brazil and Greenwich, Conn., Nov. 6, 2019 /PRNewswire/ -- OdontoCompany (the "Company"), a leading and growth-oriented dental clinic franchisor in Brazil, today announced that it has received a significant strategic investment from the Latin America fund of